Lung Cancer Stages - Discover The Truth

Lung Cancer Stages - Discover The Truth

Stages of lung cancer is when a doctor to learn the weight of the disease if the diagnosis was found to be lung cancer. The treatment of lung cancer vary depending on the size of the tumor and on how much it has spread. Staging is done to find out if the cancer has spread and, if so, to what part of the body. Lung cancer is known to spread to the brain or bone, and knowing how many have come forward to help the doctor in planning treatment more useful. Some tests used to determine if the cancer has spread include CAT (or CT) scan, MRI, bone scan, mediastinoscopy / mediastinotomy.

Lung cancer cell small Limited, extended or repeated is stage three lung cancer cell small.

Stage limited: Cancer is found in one lung and in the sap white nearby. Treatment might be one of the following: chemotherapy and radiation to the body / therapy chest up, chemotherapy with or without iradiasi kranial profilaksis, surgery followed by chemotherapy with or without iradiasi kranial profilaksis, clinical trials are testing new drug and treatment new.

Stage extensive: Cancer has spread from the lungs to the tissues and organs in the chest and other parts of the body. Treatment might be one of the following: chemotherapy and radiation to the body / therapy chest part above, therapeutic radiation to part of the body where the cancer has spread, clinical trials are testing new drug and treatment new.

Stage over and over: A cancer that has come back shows up in the lungs or in another part of the body. Treatment for kekambuhan can include be one of the following: treatment of radiation, chemotherapy, therapeutic laser, therapeutic radiation or surgical implant device for keeping the air duct open, testing clinical trials new drug.

Cell non-Small Cancer of the Lungs: lung cancer is not cells little used system of staging traditional. tumor lung cancer not cells little may have many stages because they grow more slowly than lung cancer cells small.

On the occult Stage: No tumor can be detected in the lungs at this stage, but cell-cancer cells found on the dahak. Lung cancer was found in the early stages this is often cured with surgery.

Stage 0: Cancer found only in the lungs and only in a few cells. Treatment may be surgery or therapy photodynamic, because you haven't grown up through the layer of the top of his lungs.

Stadium I: the Cancer is only found in the lungs and is surrounded by a network of normal. Treatment may consist of one of the following: Surgery, therapy radiation, clinical trials chemotherapy, clinical trials chemo prevention, clinical trials therapy photodynamic.

Stage II: cancer has increased to include the sap white nearby. Treatment can consists of: Surgery to lift the tumor and gland sap white, therapy radiation, surgery and / or therapy of radiation with or without chemotherapy.

Stage 3A: Cancer has spread to the wall of the chest or diaphragm. It can spread to the glands sap white separates both lungs or in the sap white on the other side of the chest or in the neck. Treatment for stage IIIA can be treated with surgery, but usually will consist of: Surgery, chemotherapy and maintenance other operation and maintenance radiation, therapy radiation, therapy laser and / or treatment of radiation internally.

Stage 3B: Cancer has spread to the wall of the chest and possibly the diaphragm near the lung. It also may have spread to the glands sap white in the area that separates both the lungs and the glands sap white on the other side of the chest or in the neck. Cancer stadium IIIB is usually in surgery. Treatment might be one of the following: the treatment of radiation, chemotherapy plus radiation treatment, chemotherapy, plus treatment is radiation followed by surgery, chemotherapy.

Step 4: the Cancer has spread to other parts of the body. Treatment usually includes: the treatment of radiation, chemotherapy, chemotherapy and therapy radiation, therapy laser or therapy radiation internal.

Supplicants: Cancer has returned after treatment before. Treatment may include the following: Therapy radiation to control the symptoms of cancer, chemotherapy, chemotherapy with therapeutic radiation, surgery to lift the tumor, therapy laser or therapy radiation internal radio-surgery.

A guide to rough for the survival of lung cancer in the stage of non-small based on the level of survival cells at 5 years: phase 1 is 47%, Stage II is 26%, Stage III is 8%, and Stage IV is 2%. In 5 years this is based on patients diagnosed and treated at first more than five years ago, so the level of survival when it's expected to be promising. lung cancer -stadi

I know one there's a lot of information about lung cancer that spread all over the web, and I know I can get a bit 'sad to go through a lot. I life compiled everything investigated so it can be useful for other people. I took months of research in the guide useful. No charge of course and I think You will appreciate the simplicity. About MyLungCancerGuide.com. While You're in there, You will find this article on stages of lung cancer and many items other useful, very straight forward.

Save Yourself From Lung Cancer!

  Save Yourself From Lung Cancer! 

Lung cancer is a very serious cancer. This is deadly, especially when the growth of uncontrolled cells is abnormal in the lungs has spread to organs other inside the body.

Cells-cancer cells can divide and can spread to other parts of the body to form a site for a secondary, make it more fatal.

When cancer is in the advanced, is the management of a little 'more difficult. It may help to know that that is detected early-stage lung cancer is best to ensure that the choice to put lung cancer in digger or something.

If detected early-stage lung cancer didn't happen, diagnosis in the advanced may be more difficult to manage the symptoms and it can also be too difficult.

the treatment of lung cancer really depends on the severity of disease. Know the kind of lung cancer You suffer from can help in the management of the disease.

There are two types of lung cancer, lung cancer cell small, and lung cancer non-cell small.

lung cancer cell small or karsinoma sel oat lungs covering twenty-five percent of all cases of lung cancer. The leading cause of lung cancer cancer cells little cigarette smoke.

Generally, because of symptoms of lung cancer doesn't happen in the early stages of the disease, treat it will be a big problem especially when detection happens when metastasis of cancer or cell tumor secondary that's been developed in the organs of the body to another.

lung cancer not the cells are small, on the other hand, involve a different kind of a tumor lungs. Diferensiasi kind of lung cancer not cells little depending on the type of cell exposed.

Three kinds of common of lung cancer not cells little is karsinoma sel skuamosa, adenokarsinoma, and karsinoma sel big.

Forms lung cancer cells non-small tend to grow and spread more slowly than karsinoma lung cells small.

Karsinoma sel skuamosa is lung cancer the most common non-cell small. The kind of lung cancer not cell small starting in the bronkus big and stay confined to the breast cancer other than the lungs, because of this, the cancer don't spread more quickly than the other kind.

Adenocarcinoma, the leading cause of of lung cancer not cells little is still a challenge for experts medical. Thus, experts continue to study the leading cause of cancer. Even with this research is delayed, smoke and breathe the air pure still considered as the main in the extent of lung cancer.

Doctors believe that the tumor in this kind of lung cancer is at the edge of the outside of the lungs and under the layer of bronkus. Development of lung cancer is not cells little average but the chances of survival about 10% of the stock.

Adenokarsinoma is for 30-35 percent of all cases of lung cancer in America.

lung cancer cells big is a lung cancer cell other non-small. The Tumor in this kind of cancer of the lungs is the bronchi smallest. Fifteen percent of cases of lung cancer are lung cancer cells big.

Among all lung cancer is not a cell little, what kind of lung cancer to evolve more quickly, almost to the level of the cell small lung cancer.

Of the lung case cancer is fourteen percent of all cases of cancer in the United States. At worst, twenty-eight percent of all death among patients with cancer is the case of lung cancer.

To avoid being part of the statistics on lung cancer, does not guarantee that You will get a lung cancer cell, small or even lung cancer cell slowest non-small with living a lifestyle healthy and active.

Sports regularly, eat a diet balanced and avoid exposure to pure air, including the smoke will help strengthen the immune system and this will avoid to get the disease deadly.

Lung Cancer Causes – Genetics

Lung Cancer Causes – Genetics

Genetic mutations that cause cancer generally occur in two types of genes:

• Tumor-suppressor genes, which prevent cells from endlessly copying themselves

• Proto-oncogenes, which encourage cells to keep making copies of themselves [when a proto-oncogene changes (becomes mutated), it is then called an oncogene]

• Damage to either type of gene can cause a mutation that results in uncontrolled division of cells. This uncontrolled division forms tumors.

Cancer can be the result of a genetic predisposition that is inherited from family members. It is possible to be born with certain genetic mutations or a fault in a gene that makes one statistically more likely to develop cancer later in life. Genetic predispositions are thought to either directly cause lung cancer or greatly increase one's chances of developing lung cancer from exposure to certain environmental factors.

Lung cancer is the most common cause of cancer death worldwide, with over one million cases annually. The five-year relative survival rate for lung cancer is only 10-15%. In approximately 90% of the cases, cigarette smoking is the main etiologic factor.

We often associate lung cancer with tobacco, but 25-year-old Matthew Hiznay is a lung cancer patient who never smoked a cigarette. He is battling a rare form of genetic lung cancer for the second time in less than two years.

Screening tumor samples for cancer-causing genetic mutations can help physicians tailor treatment to specifically target those mutations in patients with advanced lung cancer.

Other risk factors include radon exposure, or exposure to nickel-, chrome-, cadmium-, arsenic- and asbestos compounds. Lung cancer sometimes aggregates in families, suggesting that genetic predisposition may also play a role in the development of lung cancer.

It is unlikely that a single specific abnormality causes all lung cancer. It probably takes a variety of mutations to start the devastating chain of events leading to cancer. The following mutations are among those under investigation:

• EGFR mutations: EGFR (epidermal growth factor receptor gene) is a family of genes that can mutate and promote tumor growth. This gene mutation is often implicated in non-smokers. HER2 is a related gene under study that plays a role in regulating cell growth.

• BPDE-caused mutations: The chemical BPDE, a byproduct of tobacco smoke, is involved with a number of genetic mutations, including those to an oncogene called K-ras and to three tumor-suppressor genes known as p53, PPP2R1B, and p16. (Tumors that contain the p53 mutation may also be more resistant to chemotherapy.)

• Rb mutations: Another important contributor to lung cancer is a genetically defective protein called retinoblastoma (Rb), which is associated with very aggressive tumors. Low levels of the normal Rb gene may sometimes predict aggressive cancer, especially in patients with small cell lung cancer.

• Abnormalities in the FHIT gene: Such abnormalities may cause the cells lining the lung to become more vulnerable to the effects of tobacco smoke and other cancer-causing substances.

• Alpha1-antitrypsin mutations: People who carry a common variation in the gene for alpha1-antitrypsin -- a substance that normally protects the walls of the alveoli in the lungs -- are 70% more likely to develop lung cancer than those without the mutation, regardless of whether they smoke.

• Many other gene mutations have been implicated including BRCA1,RAP80, RRM1, ERCC1, and TS. Scientists continue to explore the complex relationship between various genes that play a role in cell production and what environmental factors give rise to cancer.

• Medical centers are beginning to test tumors for specific gene mutations affecting tumor growth. The hope is that an accurate "genetic fingerprint" can help doctors prescribe the most effective and appropriate treatment options.

When Hiznay was about to begin his second year of medical school at the University of Toledo College of Medicine, a persistent dry cough sent him to his family doctor, who made a preliminary diagnosis of a lung disease — sarcoidosis — and referred him to Cleveland Clinic.

 

A new study detected one of ten such mutations in 54 percent of the 516 lung cancer patients tested at diagnosis. The results enabled doctors to select the most appropriate drug designed to block the identified mutation and choose other treatment options for those patients whose tumors did not have a mutation.

Lung Cancer Causes – Air Pollution

Lung Cancer Causes – Air Pollution

Air pollution caused by industry, power plants and vehicles of various types raises the likelihood of developing Lung Cancer in persons who are exposed polluted air. Approximately one-percent of the deaths from Lung Cancer are attributed to breathing polluted air. Prolonged exposure to air pollution may carry risks for developing Lung Cancer which are similar to Passive Smoking; according to experts. Air pollution can contain trace amounts of diesel exhaust, coal products, and other industrial substances.

Air pollution is a significant environmental risk factor for lung cancer. For every increase of 5 μg/m3 of particulate matter (PM) smaller than 2.5 μm in diameter (PM2.5) in the environment, the risk of lung cancer rises by 18%; for every elevation of 10 μg/m3 in PM smaller than 10 μm (PM10), the risk increases by 22% (Raaschou-Nielsen et al., 2013). Anthropogenic PM2.5 is associated with 220,000 lung cancer mortalities annually (Anenberg et al., 2010). Based on sufficient evidence of carcinogenicity, the International Agency for Research on Cancer (IARC) Working Group recently classified outdoor air pollution and related PM as Group 1 carcinogenic to humans (Loomis et al., 2013). However, the carcinogenic mechanism of air pollution remains to be dissected using systematic approaches.

Air pollution is killing about 4,400 people in China every single day, according to a new study. Exposure to air pollution has many impacts across the lifespan and has now been linked to survival of patients after being diagnosed with lung cancer, the most commonly diagnosed cancer over the past several decades.

People most susceptible to severe health problems from air pollution are:

• Individuals with heart disease - such as coronary artery disease or congestive heart failure

• Individuals with lung disease - such as asthma, emphysema or chronic obstructive pulmonary disease (COPD)

• Pregnant women

• Outdoor workers

• Children under age 14, whose lungs are still developing

• Athletes who exercise vigorously outdoors

Air pollution is a major environmental issue affecting people across the world. According to the World Health Organisation(WHO), more than 2 million people worldwide die every year from air pollution. Of all the air pollutants, fine particulate matter (PM) is one of the most hazardous pollution for the human health. The particulate matter causes about 9% of lung cancer deaths worldwide, 5% of cardiopulmonary deaths and about 1% of respiratory infection deaths. According to the WHO, there is mounting evidence that concentration of particulate matter is increasing in Asia. Particulate matter mostly originates from dust storms, grassland fires, burning of fossil fuels in vehicles, power plants, but also various industrial plants generate significant amounts of particulates. The interactive map shows that South Asia is badly hit by pollution caused by particulate matter. While Pakistan has the highest concentration of particulate matter, countries like Bangladesh, Nepal and India are placed by the WHO in a category called “unhealthy for the sensitive people”. That means people in these countries suffering from respiratory and heart disease, as well as elderly and children should limit outdoor exertion. Air pollution in China is as bad, if not worse, than in India but according to the WHO,the particulate matter concentration in China and in countries such as Myanmar, Sri Lanka, South Korea and Indonesia remains moderate. There is the least presence of particulate matter in Philippines, Malaysia, Thailand, Singapore and Japan.

In a groundbreaking Oct. 17 announcement, the International Agency for Research on Cancer (IARC), an agency of the World Health Organization, classified outdoor air pollution as a known cause of lung cancer. The agency also found that particulate matter (PM), a major component of air pollution better known as “soot,” is a known cause of lung cancer.  After an extensive review of more than 1,000 scientific studies from five continents, a committee of some of the world’s leading experts on air pollution and health convened by the IARC Monographs Programme concluded that there is sufficient evidence that exposure to outdoor air pollution causes lung cancer. Though IARC has previously evaluated the health impacts of various components of outdoor air pollution, such as diesel engine exhaust, metals, and solvents, this is the first time that outdoor air pollution in general has been classified as a cause of cancer.

High air pollution levels can cause immediate health problems:

• Aggravated cardiovascular and respiratory illness

• Added stress to heart and lungs, which must work harder to supply the body with oxygen

• Damaged cells in the respiratory system

Researchers from Berkeley Earth, a California-based climate research organization, calculated that about 1.6 million people in China die every year from health issues caused by the country’s notoriously polluted air.

“We thought that if ambient air pollution is a carcinogen that can drive lung cancer development, then exposure to air pollution in patients already diagnosed with lung cancer could promote the progression of their disease through the same biological pathways,” said Sandrah Eckel, assistant professor of preventive medicine at the Keck School of Medicine of USC and lead author of the research. Eckel and colleagues at the Keck School decided to more closely explore the question of whether lung cancer survival times might be affected by air pollution.

The particulate matter represents a complex mixture of solid and liquid particles suspended in the air, many of which are hazardous. These particles are either directly emitted into the air by sources such as smoke, dust, pollen, or formed in the atmosphere by transformation of emitted gases. The particulate matter can adversely affect human health and also have an impact on climate and precipitation. On the basis of size, the particulate matter is divided into two categories. The particles up to 10 micrometers in size are called PM 10 and smaller particles of 2.5 micrometer in size are called PM2.5. The WHO has measured outdoor air pollution caused by both types of the particulate matter and according to these findings, air can be contaminated by a range of different particles of which many can harm our health, especially very small particles that enter into the lungs and bloodstream and cause the most serious health problems. In Asia, like in other regions of the world, pollution caused by particulate matter is spreading to new areas. The graph, based on the data obtained from the WHO, ranks Asian countries according to the PM10 level in the air. As the data suggests, Pakistan is the most polluted country in the region in terms of particulate matter concentration in the air. It is followed by Bangladesh, India, Nepal, China, Myanmar, Sri Lanka, South Korea, Indonesia, Philippines, Malaysia, Thailand, Singapore and Japan.

The IARC evaluation found strong scientific evidence of an increased risk of lung cancer with increasing exposure to air pollution in general and issued a similar finding for particulate matter. Although the composition of air pollution and levels of exposure can vary dramatically between locations worldwide, the IARC conclusions apply to all regions of the world. The IARC assessment of the link between PM and lung cancer contrasts with findings from the U.S. Environmental Protection Agency’s (EPA) 2009 assessment of the PM health science,  which classified the PM-lung cancer scientific evidence as only “suggestive of a causal relationship.”

Long-term exposure to polluted air can have permanent health effects:

• Accelerated aging of the lungs

• Loss of lung capacity

• Decreased lung function

• Development of diseases such as asthma, bronchitis, emphysema, and possibly cancer

• Shortened life span

According to the study, more than one-third of the Chinese population regularly breathe air that would be considered “unhealthy” by U.S. standards.

Their research, published this month in Thorax, shows that the length of time that lung cancer patients live after diagnosis varies depending on their exposures to regional pollution. Researchers found that the median survival for people diagnosed with early stage lung cancers who lived in areas with high levels of regional pollution was approximately three years shorter than for people who lived in areas with lower levels of pollution.

Air pollution in some Asian cities is so bad that at times, the cities are enveloped by a blanket of smog that impedes visibility. According to the WHO,air pollution has worsened in Asian cities in recent years and presents a threat to human health. In many cities the levels of fine particulate matter - a key pollutant in terms of its impact on human health - are exceeding the critical limit (as defined by the WHO), specifically in densely populated, fast-growing and less developed countries like China, India, Pakistan and Bangladesh. Even in small Asian cities like Kathmandu, the particulate matter level exceeds the most lenient of several targets recommended by the WHO. Over the last few years, China has been in the news for heavy pollution in its cities with the skies being completely blanketed by smog. India and Pakistan, however, have the dubious distinction of having the most polluted cities in the region. If we take a look at the statistics concerning capital cities in Asia, the air pollution caused by the particulate matter is worst in Delhi. It is closely followed by Islamabad, Dhaka, Beijing and Kathmandu.

The IARC findings have significant implications for U.S. air pollution control efforts. The EPA sets air quality standards to protect public health based on assessments of the health effects of individual pollutants rather than outdoor air pollution in general.  Air pollution control rules are then developed for specific sources of these individual pollutants in order to achieve the health-based standards.

As The New York Times notes, air pollution — particularly exposure to fine airborne particles — can cause a variety of health problems, including asthma, lung cancer, heart disease and stroke. The World Health Organization said last year that 7 million people die annually because of exposure to polluted air.

“We focused on California, since there are a wide range of air pollution levels here and one of the largest and longest running air quality monitoring networks and cancer registry system in the U.S.,” Eckel said.

Air pollution is one of the main causes of premature deaths in the world. Of all major global health risks, outdoor air pollution in the form of fine particles is found to be much more dangerous for public health than previously known - contributing annually to over 2 million premature deaths worldwide. The WHO global study ranks air pollution as one of the top 10 killers in the world, with 65 percent of all air pollution deaths occurring in Asia. In 2010 alone, particulate matter pollution was the fourth-leading risk factor for deaths in China, behind high blood pressure and smoking. Across the region, increasing levels of particulate matter are causing higher numbers of premature deaths. The graph reveals the human toll due to outdoor air pollution in 2008, which is the latest comparative data available. A record number of people have died due to air pollution in the region. In the year 2008 alone, over half-million people have died in China and India. Other countries in the region have also suffered heavily from air pollution. On top of that, the future looks very bleak. By 2050, urban air pollution is estimated to cause up to 3.6 million premature deaths worldwide each year, mostly in China and India.

However, in the real world, we are exposed to a toxic soup of various different air pollutants and chemical mixtures, which interact and combined can have a greater health impact than each of the individual components. This concept was recognized more than 40 years ago and incorporated by Congress into the Clean Air Act of 1970, which provides the foundation of today’s air pollution control efforts. In providing instruction to EPA for developing air pollutant health assessments, Congress expressly required EPA to consider “the types of air pollutants which, when present in the atmosphere, may interact with such pollutant to produce an adverse effect on public health or welfare” (emphasis added).

China has struggled for years to control its air pollution problems, which are primarily caused by the burning of coal in factories and power plants, as well as vehicle use.

Eckel and her team of researchers looked at lung cancer data from over 350,000 patients in the California Cancer Registry who were diagnosed with lung cancer between 1988-2009. From the extensive and detailed dataset, the team assigned air pollution exposure levels based on the average exposure at the patient’s residence at diagnosis.

Given the generally accepted scientific consensus that even very low levels of exposure to environmental pollution increases the risk of cancer, the IARC findings suggest that reductions in U.S. air pollution beyond levels set as “safe” for individual pollutants, especially for particulate matter and transportation-related pollutants that were the focus of many of the reviewed studies, would provide additional public health benefits in avoided lung cancers.

In April, Greenpeace reported that, of 360 cities in China, less than 10 percent had successfully met national air quality standards in the first quarter of 2015.

Treatments For Lung Cancer Stage 2

Treatments For Lung Cancer Stage 2

Chemotherapy

Chemotherapy utilizes strong chemicals that interfere with the cell division process damagingProteinsor DNA sothat cancer cells will commit suicide. These treatments target any rapidly dividing cells (notjust cancer cells), but normal cells usually can recover from anychemicalinduceddamage while cancercells cannot. Chemotherapy is considered systemicbecause its medicines travel throughout the entirebody, killing the original tumor cells as wellas cancer cells that have spread throughout the body.

Chemotherapy for lung cancer uses drugs that are injected into a vein or swallowed to enter the bloodstream and killcancerous cells throughout the body.

A medical oncologist will usually prescribechemotherapy drugs for lung cancer to betaken intravenously, but there are also drugsavailable in tablet, capsule, and liquid form.Chemotherapy treatment occurs in cycles sothe body has time to heal between doses, anddosages are determined by the type of lungcancer, the type of drug, and how the personresponds to treatment. Medicines may beadministered daily, weekly, or monthly, and cancontinue for months or even years.

Chemotherapy is the main lung cancer treatment for small cell lung cancer, using a combination of drugs and possiblepaired with radiation. For nonsmallcell lung cancer, our chemotherapy uses include:

• ·         Before surgery (neoadjuvant) to shrink a tumor

• ·         After surgery (adjuvant) to kill any remaining cancer cells

• ·         As the main treatment (with radiation) for inoperable cancer or for people who aren’t healthy enough for surgeryor don’t want to undergo it

• ·                  With a targeted therapy to control laterstagedisease

Chemotherapy carries several common side effects, but they depend on the type of chemotherapy andthe health of the patient. These include nausea and vomiting, appetite loss, diarrhea, hair loss, fatiguefrom anemia, infections, bleeding, and mouth sores. Many of these side effects are only temporarily feltduring treatment, and several drugs exist to help patients cope with the symptoms.

CyberKnife for Lung Cancer

CyberKnife is an advanced form of external radiation sometimes called radiosurgery, though it does not involve surgery.It uses imageguidancesystems and a robot arm rotating around your body to:

• ·         Deliver hundreds of tiny radiation beams at various angles, with submillimeterprecision

• ·         Track and adjust for tumor motion while you breathe, minimizing the harm to surrounding areas and delivering ahigher dose of radiation straight to the cancer

• ·                  Reduce the number of lung cancer treatment sessions

The CyberKnife is the world’s first and only radiosurgery system designed to pinpoint and destroy tumors in the body. In many cases, the treatment offers new hope to patients who were considered untreatable or inoperable, who may be looking for an alternative to surgery, or who have been previously exposed to the maximum allowable dose of radiation but still require further treatment. 

Twenty-five of 29 tumors were evaluable for local control, with 27 tumors (93 %) considered in-field recurrences. In-field crude local control rate was 80 % (20/25) with 1 and 2-year actuarial rates of 78.6 and 65.5 %, respectively. One and 2-year actuarial survival rates were 52.3 and 37.0 %, respectively. One and 2-year actuarial progression-free survival rates were 56.7 and 37.0 %, respectively. Fifty-five percent of patients reported acute/chronic grades 1 and 2 toxicities. No grade 3 or higher toxicities were reported.